Vascular effects of ipsapirone are related with subtypes of alpha 1-adrenergic receptors
Arch. med. res
;
24(2): 161-8, jun. 1993. ilus, tab
Article
Dans Anglais
| LILACS
| ID: lil-177003
RESUMO
The aim of this study was to provide further evidence about the participation of Ó1-adrenoceptors in the vascular responses elicited by impsapirone. This 5-HT 1A agonist displayed vasodilator activity only when aortic rings were precontracted by Ó-adrenergic compounds. The relaxant effect was particulary evident when rings were precontracted with methoxamine (selective Ó1A-adrenergic agonist).On the other hand, ipsapirone but chloroethylclonidine (selective Ó1B-adrenergic antagonist), clearly displaced norepinephrine and methoxaminevasocontractile concentration-response curves to the right. Fanally, ipsapirone protected the Ó-adrenoceptors from the irreversible blockade provoked by phenoxybenzamine, as judged by thenorepinephrine contraction and stimulated phosphatidylinositil labeling. Accordingly the relaxant effect elicited by ipsapirone in aortic rings precontracted with Ó-adrenergic agonists and the protective action against blockade by phenoxybenzamine shown by this agent are proof of its ability to occupy Ó1-adrenoceptors. Specifically, Ó1A-adrenergic receptors seem to be involved in ipsapirone vascular effects, since this agent selectively relaxed aortic preparation precontracted with methoxamine and unlike chloroethylclonidine, clearly inhibited the contractile effect of this agonist. In summary, the present findings can be explained by accepting that ipsapirone may act as an antagonist at Ó1A-adrenoceptors
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Phénoxybenzamine
/
Norépinéphrine
/
Récepteurs alpha-adrénergiques
Limites du sujet:
Animaux
langue:
Anglais
Texte intégral:
Arch. med. res
Thème du journal:
Médicament
Année:
1993
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS